Background: It is unknown whether longitudinal stability versus instability in subjective cognitive decline (SCD) is a modifying factor of the association between SCD and risk of incident Alzheimer’s disease (AD) dementia.
Objective: We tested the modifying role of temporal stability of the SCD report on AD dementia risk in cognitively normal elderly individuals.
Methods: We analyzed data of 1,990 cognitively normal participants from the longitudinal AgeCoDe Study. We assessed SCD with/without associated worries both at baseline and first follow-up 18 months later. Participants were then classified either as (a) Controls (CO, with no SCD at both baseline and follow-up 1, n = 613), (b) inconsistent SCD (with SCD reported only at baseline or at follow-up 1, n = 637), (c) consistent SCD but without/or with inconsistent worries (n = 610) or (d) consistent SCD with worries (n = 130). We estimated incident AD dementia risk over up to 6 years for each group with Cox-Proportional Hazard Regression analyses adjusted for age, gender, education, ApoE4 status, and depression.
Results: Compared to CO, inconsistent SCD was not associated with increased risk of incident AD dementia. In contrast, risk was doubled in the group of consistent SCD without/ with inconsistent worries, and almost 4-fold in the group of consistent SCD with worries. These results could be replicated when using follow-up 1 to follow-up 2 response patterns for group definition.
Conclusion: These findings suggest that longitudinal stability versus instability is an important modifying factor of the association between SCD and AD dementia risk. Worrisome SCD that is also consistently reported over time is associated with greatly increased risk of AD dementia.
DufouilC, FuhrerR, AlpérovitchA (2005) Subjective cognitive complaints and cognitive decline: Consequence or predictor? The epidemiology of vascular aging study. J Am Geriatr Soc53, 616–621.
ReisbergB, ShulmanMB, TorossianC, LengL, ZhuW (2010) Outcome over seven years of healthy adults with and without subjective cognitive impairment. Alzheimers Dement6, 11–24.
4.
MitchellAJ, BeaumontH, FergusonD, YadegarfarM, StubbsB (2014) Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: Meta-analysis. Acta Psychiatr Scand130, 439–451.
5.
VisserPJ, VerheyF, KnolDL, ScheltensP, WahlundL, Freund-LeviY, TsolakiM, MinthonL, WallinAK, HampelH, BürgerK, PirttilaT, SoininenH, RikkertMO, VerbeekMM, SpiruL, BlennowK (2009) Prevalence and prognostic value of CSF markers of Alzheimer’s disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: A prospective cohort study. Lancet Neurol8, 619–627.
6.
ChételatG, VillemagneVL, BourgeatP, PikeKE, JonesG, AmesD, EllisKA, SzoekeC, MartinsRN, O’KeefeGJ, SalvadoO, MastersCL, RoweCC (2010) Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol67, 317–324.
7.
AmariglioRE, BeckerJA, CarmasinJ, WadsworthLP, LoriusN, SullivanC, MayeJE, GidicsinC, PepinLC, SperlingRA, JohnsonKA, RentzDM (2012) Subjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia50, 2880–2886.
8.
SnitzBE, LopezOL, McDadeE, BeckerJT, CohenAD, PriceJC, MathisCA, KlunkWE (2015) Amyloid-β imaging in older adults presenting to a memory clinic with subjective cognitive decline: A pilot study. J Alzheimers Dis48(Suppl 1), 151–159.
9.
SnitzBE, WeissfeldLA, CohenAD, LopezOL, NebesRD, AizensteinHJ, McDadeE, PriceJC, MathisCA, KlunkWE (2015) Subjective cognitive complaints, personality and brain amyloid-beta in cognitively normal older adults. Am J Geriatr Psychiatry23, 985–993.
10.
JessenF, AmariglioRE, van BoxtelM, BretelerM, CeccaldiM, ChételatG, DuboisB, DufouilC, EllisKA, van der Flier, WiesjeM, GlodzikL, van Harten, ArgondeC, de Leon, MonyJ, McHughP, MielkeMM, MolinuevoJL, MosconiL, OsorioRS, PerrotinA, PetersenRC, RabinLA, RamiL, ReisbergB, RentzDM, SachdevPS, de la Sayette, Vincent, SaykinAJ, ScheltensP, ShulmanMB, SlavinMJ, SperlingRA, StewartR, UspenskayaO, VellasB, VisserPJ, WagnerM (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement10, 844–852.
11.
JessenF, WolfsgruberS, WieseB, BickelH, MöschE, KaduszkiewiczH, PentzekM, Riedel-HellerSG, LuckT, FuchsA, WeyererS, WerleJ, van den Bussche, Hendrik, SchererM, MaierW, WagnerM (2014) AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimers Dement10, 76–83.
12.
JackCR, KnopmanDS, JagustWJ, PetersenRC, WeinerMW, AisenPS, ShawLM, VemuriP, WisteHJ, WeigandSD, LesnickTG, PankratzVS, DonohueMC, TrojanowskiJQ (2013) Tracking pathophysiological processes in Alzheimer’s disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol12, 207–216.
13.
ComijsHC, DeegDJH, DikMG, TwiskJWR, JonkerC (2002) Memory complaints; the association with psycho-affective and health problems and the role of personality characteristics. A 6-year follow-up study. J Affect Disord72, 157–165.
14.
SchmidtkeK, PohlmannS, MetternichB (2008) The syndrome of functional memory disorder: Definition, etiology, and natural course. Am J Geriatr Psychiatry16, 981–988.
15.
RobertsJL, ClareL, WoodsRT (2009) Subjective memory complaints and awareness of memory functioning in mild cognitive impairment: A systematic review. Dement Geriatr Cogn Disord28, 95–109.
16.
EdmondsEC, Delano-WoodL, GalaskoDR, SalmonDP, BondiMW (2014) Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment. J Int Neuropsychol Soc20, 836–847.
17.
RobertsRO, KnopmanDS, MielkeMM, ChaRH, PankratzVS, Christianson, TeresaJH, GedaYE, BoeveBF, IvnikRJ, TangalosEG, RoccaWA, PetersenRC (2014) Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology82, 317–325.
18.
ParkMH, HanC (2015) Is there an MCI reversion to cognitively normal? Analysis of Alzheimer’s disease biomarkers profiles. Int Psychogeriatr27, 429–437.
19.
KoepsellTD, MonsellSE (2012) Reversion from mild cognitive impairment to normal or near-normal cognition: Risk factors and prognosis. Neurology79, 1591–1598.
20.
SachdevPS, LipnickiDM, CrawfordJ, ReppermundS, KochanNA, TrollorJN, WenW, DraperB, SlavinMJ, KangK, LuxO, MatherKA, BrodatyH (2013) Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: A population-based study. PLoS One8, e59649.
LuckT, Riedel-HellerSG, KaduszkiewiczH, BickelH, JessenF, PentzekM, WieseB, KoelschH, van den Bussche, Hendrik, AbholzH, MoeschE, GorferS, AngermeyerMC, MaierW, WeyererS (2007) Mild cognitive impairment in general practice: Age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dement Geriatr Cogn Disord24, 307–316.
24.
JessenF, WieseB, BickelH, Eiffländer-GorferS, FuchsA, KaduszkiewiczH, KöhlerM, LuckT, MöschE, PentzekM, Riedel-HellerSG, WagnerM, WeyererS, MaierW, van den BusscheH, AgeCoDe Study Group (2011) Prediction of dementia in primary care patients. PLoS One6, e16852.
25.
ZaudigM, HillerW (1996) Sidam-Handbuch.: Strukturiertes Interview für die Diagnose einer Demenz vom Alzheimer Typ, der Multi-Infarkt- (oder vaskulären) Demenzen und Demenzen anderer Ätiologien nach DSM-III-R, DSM-IV und ICD-10., Huber, Bern.
26.
RosenWG, TerryRD, FuldPA, KatzmanR, PeckA (1980) Pathological verification of ischemic score in differentiation of dementias. Ann Neurol7, 486–488.
27.
FolsteinMF, FolsteinSE, McHughPR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
28.
YesavageJA, BrinkTL, RoseTL, LumO, HuangV, AdeyM, LeirerVO (1982) Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res17, 37–49.
29.
KönigW, LüttingerP, MüllerW (1988) A comparative analysis of the development and structure of educational systems: Methodological foundations and the construction of a comparative educational scale, Universität Mannheim, Institut für Sozialwissenschaften.
30.
McKhannG, DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34, 939–944.
31.
RománGC, TatemichiTK, ErkinjunttiT, CummingsJL, MasdeuJC, GarciaJH, AmaducciL, OrgogozoJM, BrunA, HofmanA (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology43, 250–260.
32.
ReisbergB, FerrisSH, de LeonMJ, CrookT (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry139, 1136–1139.
33.
BlessedG, TomlinsonBE, RothM (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry114, 797–811.
34.
VerlindenVJA, van der GeestJN, de BruijnRFAG, HofmanA, KoudstaalPJ, IkramMA (2016) Trajectories of decline in cognition and daily functioning in preclinical dementia. Alzheimers Dement12, 144–153.
35.
SperlingRA, AisenPS, BeckettLA, BennettDA, CraftS, FaganAM, IwatsuboT, JackCR, KayeJ, MontineTJ, ParkDC, ReimanEM, RoweCC, SiemersE, SternY, YaffeK, CarrilloMC, ThiesB, Morrison-BogoradM, WagsterMV, PhelpsCH (2011) Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 280–292.
36.
RentzDM, Parra Rodriguez, MarioA, AmariglioR, SternY, SperlingR, FerrisS (2013) Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: A selective review. Alzheimers Res Ther5, 58.
MosconiL, SantiS, de, BrysM, TsuiWH, PirragliaE, Glodzik-SobanskaL, RichKE, SwitalskiR, MehtaPD, PraticoD, ZinkowskiR, BlennowK, de Leon, MonyJ (2008) Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints. Biol Psychiatry63, 609–618.
39.
WolfsgruberS, JessenF, KopparaA, KleineidamL, SchmidtkeK, FrölichL, KurzA, SchulzS, HampelH, HeuserI, PetersO, ReischiesFM, JahnH, LuckhausC, HüllM, GertzH, SchröderJ, PantelJ, RienhoffO, RütherE, HennF, WiltfangJ, MaierW, KornhuberJ, WagnerM (2015) Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI. Neurology84, 1261–1268.
40.
JessenF, WieseB, BachmannC, Eifflaender-GorferS, HallerF, KölschH, LuckT, MöschE, van den Bussche, Hendrik, WagnerM, WollnyA, ZimmermannT, PentzekM, Riedel-HellerSG, RombergH, WeyererS, KaduszkiewiczH, MaierW, BickelH (2010) Prediction of dementia by subjective memory impairment: Effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry67, 414–422.
ReidLM, Maclullich, AlasdairMJ (2006) Subjective memory complaints and cognitive impairment in older people. Dement Geriatr Cogn Disord22, 471–485.
43.
KennedyGJ, KelmanHR, ThomasC (1991) Persistence and remission of depressive symptoms in late life. Am J Psychiatry148, 174–178.
44.
GaoS, UnverzagtFW, HallKS, LaneKA, MurrellJR, HakeAM, Smith-GambleV, HendrieHC (2014) Mild cognitive impairment, incidence, progression, and reversion: Findings from a community-based cohort of elderly African Americans. Am J Geriatr Psychiatry22, 670–681.
45.
BeauducelA, HilgerN (2015) Extending the debate between Spearman and Wilson 1929: When do single variables optimally reproduce the common part of the observed covariances?Multivariate Behav Res50, 555–567.
